Latest Regulatory Process News

Dataworks has officially launched BetGuard, iGaming Ontario's Centralised Self-Exclusion tool, alongside a dedicated Contact Centre, marking its expansion into a second regulated jurisdiction for responsible gambling technology.

Chariot Resources has broadened its Nigerian lithium acquisition by adding a key small-scale mining licence and converting three leases to mining leases, extending the acquisition timeline and increasing regulatory costs.

Lumos Diagnostics has reached a key enrolment milestone in its BARDA-backed FebriDx paediatric trial, unlocking a US$670,000 payment and advancing its FDA submission pathway to expand use in children aged 2-12 years.

Diamond Infraco, backed by IFM Global Infrastructure Fund, has lodged a Takeovers Panel application alleging material disclosure deficiencies in Atlas Arteria's takeover bid documents, centering on governance rights tied to the Chicago Skyway asset.

Santana Minerals has corrected its timeline for settling the purchase of 3,680 hectares for its Bendigo-Ophir Project, extending the deadline to the earlier of mid-2030 or 12 months after mining consents are granted.

PEXA Group delivered a 7.3% rise in Australian property transaction volumes in 3Q26 and saw steady UK remortgage growth despite macroeconomic uncertainty. The company reaffirmed its FY26 guidance, aiming for NPAT at the top of its $15m-$25m range.

Metal Bank is pushing towards near-term gold production in Western Australia and expanding its critical minerals footprint in Queensland, backed by new processing partnerships and exploration milestones.

Acrux pivots from generics to developing a Female Testosterone therapy for HSDD, leveraging FDA feedback and a strong US market opportunity.

Whitehaven Coal’s March quarter production fell 14% due to seasonal wet weather in Queensland, but coal prices rose sharply and refinancing cut interest costs by up to A$55 million annually.

Elevate Uranium Ltd pushes back its U-pgradeTM pilot plant results to August 2026 amid operational tweaks, while reporting a doubled resource grade at Marenica and a 76.2 Mlb uranium resource at Koppies.

PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.

Rokeby Resources (ASX:RKB) has secured the Omeo Gold Project in Victoria, adding a historical resource of 320,000 ounces at 4.0 g/t Au and launching a $4 million capital raise. The acquisition ushers in leadership changes and sets a clear path for resource expansion.